Hyuga Primary Care CoTSE:7133 +2.65%80 EBITDA Margin % is 10.83% as of Mar. 2026, which is 15% above its 10-year median of 9.42. GuruFocus rates TSE:7133 with a GF Score™ of 80/100 and a GF Value™ of 円1,948.02 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Hyuga Primary Care Co ranks worse than 53.08% on this metric.
Hyuga Primary Care Co (TSE:7133) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Hyuga Primary Care Co EBITDA Margin % Related Terms
Hyuga Primary Care Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Hyuga Primary Care Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7133 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Hyuga Primary Care Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hyuga Primary Care Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hyuga Primary Care Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Hyuga Primary Care Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hyuga Primary Care Co (TSE:7133) has a EBITDA Margin % of 10.83% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hyuga Primary Care Co and its competitors. This is 15% above median its historical median of 9.42. Over the past decade, Hyuga Primary Care Co's EBITDA Margin % has ranged from 3.72 to 12.94. According to the industry distribution chart, Hyuga Primary Care Co ranks #353 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 53.1%.
Is Hyuga Primary Care Co's EBITDA Margin % too high?
Hyuga Primary Care Co's current EBITDA Margin % of 10.83% is 15% above median its 10-year median of 9.42. Over the past 10 years, this metric has ranged from a low of 3.72 to a high of 12.94. The Healthcare Providers & Services industry median EBITDA Margin % is 10.19. Hyuga Primary Care Co's value of 10.83% is 6.3% above this industry median. Based on the distribution chart, Hyuga Primary Care Co ranks #353 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Hyuga Primary Care Co has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hyuga Primary Care Co's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hyuga Primary Care Co ranks #353 out of 665 companies for EBITDA Margin %. This places Hyuga Primary Care Co in the lower half of its industry. The industry median EBITDA Margin % is 10.19. Hyuga Primary Care Co's value of 10.83% is 6.3% above this benchmark. Historically, Hyuga Primary Care Co's own EBITDA Margin % has ranged from 3.72 to 12.94 over the past decade. While the company's 10-year median is 9.42 vs. the industry median of 10.19, Hyuga Primary Care Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.19, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hyuga Primary Care Co's current EBITDA Margin % of 10.83% is 6.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hyuga Primary Care Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hyuga Primary Care Co's current EBITDA Margin % is 10.83%, which is 15% above median its own 10-year median of 9.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyuga Primary Care Co stock overvalued right now?
Based on GuruFocus' analysis, Hyuga Primary Care Co (TSE:7133) is currently considered Significantly Undervalued. The stock's GF Value™ is 円1,948.02, compared to a current price of 円1,164.00 — trading 40.2% below its estimated fair value. The current EBITDA Margin % is 10.83%, which is 15% above median its 10-year median of 9.42 and 6.3% above the Healthcare Providers & Services industry median of 10.19. Hyuga Primary Care Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Hyuga Primary Care Co (TSE:7133), the current EBITDA Margin % is 10.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hyuga Primary Care Co (TSE:7133) Overvalued in 2026?
Based on GuruFocus' analysis, Hyuga Primary Care Co stock appears to be undervalued.
The current stock price of 円1,164.00 is trading 40.2% below its estimated GF Value™ of 円1,948.02.
GuruFocus considers Hyuga Primary Care Co to be Significantly Undervalued.
Key valuation signals for TSE:7133:
EBITDA Margin %: 10.83% (15% above median its 10-year median of 9.42)
GF Value™: 円1,948.02 vs. price of 円1,164.00 (40.2% below fair value)
Industry Position: 6.3% above the Healthcare Providers & Services median (#353 of 665)
No single metric tells the full story. See the TSE:7133 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hyuga Primary Care Co Ltd is predominantly engaged in the operation of special nursing homes for the elderly, group homes, paid nursing homes with nursing care, residential area-type paid nursing homes, elderly housing with services, and small-scale multifunctional home care. The group's reportable operating segments are Home Visit Pharmacy Business, Kirari Prime Business, and the Primary Care Home Business. In addition, it is involved in other businesses such as Thai Support and the ICT Business. The majority of the group's revenue is generated from the Primary Care Home business, which is engaged in operating residential nursing homes that provide regular visits and on-demand visiting care nursing services.
80GF Score
Get the complete analysis for TSE:7133
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7133 has been successfully added to your 
